Furthermore, culturing chimeric antigen receptor (CAR) T cells in the presence of PI3K or mTOR inhibitors during ex vivo expansion can improve their metabolic fitness, persistence, and anti-tumor efficacy upon infusion. Here, MTOR is linked to neoplasm.